Mark K. Oki is SVP & CFO and Sec at Alexza Pharmaceuticals Inc. (ALXA). They have made 3 open-market trades across 2 companies since 2012, most recently 2025-09-18.
CIK 0001491847
2 open-market purchases totalling $70K since 2018, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACHV | SELL | 2025-09-18 | 2025-09-22 | $2.92 | $292K | +6.3% | +70.3% | +48.7% |
| ACHV | BUY | 2025-03-17 | 2025-03-19 | $2.89 | $29K | -4.6% | -19.6% | +6.4% |
| VVUS | BUY | 2018-11-06 | 2018-11-07 | $4.07 | $41K | -24.5% | -26.0% | +29.5% |
| ALXA | SELL · 10b5-1 | 2012-08-27 | 2012-08-29 | $4.14 | $41K | -39.4% | -2.5% | -2.5% |
| ALXA | SELL · 10b5-1 | 2012-06-06 | 2012-06-08 | $0.34 | $11K | -39.4% | -2.5% | -2.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.